SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018641
Filing Date
2016-05-09
Accepted
2016-05-09 17:14:40
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20160331.htm 10-Q 1344669
2 EX-31.1 dvax-ex311_7.htm EX-31.1 18070
3 EX-31.2 dvax-ex312_9.htm EX-31.2 18000
4 EX-32.1 dvax-ex321_6.htm EX-32.1 6199
5 EX-32.2 dvax-ex322_8.htm EX-32.2 6256
  Complete submission text file 0001564590-16-018641.txt   5131183

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20160331.xml EX-101.INS 1176624
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20160331.xsd EX-101.SCH 31207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20160331_cal.xml EX-101.CAL 44054
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20160331_def.xml EX-101.DEF 106501
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20160331_lab.xml EX-101.LAB 288756
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20160331_pre.xml EX-101.PRE 216151
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 161632693
SIC: 2834 Pharmaceutical Preparations